372 related articles for article (PubMed ID: 18853416)
21. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature.
Fraenkel M; Kim M; Faggiano A; de Herder WW; Valk GD;
Endocr Relat Cancer; 2014 Jun; 21(3):R153-63. PubMed ID: 24322304
[TBL] [Abstract][Full Text] [Related]
22. Geographic and demographic features of neuroendocrine tumors in the United States of America: A population-based study.
Gosain R; Ball S; Rana N; Groman A; Gage-Bouchard E; Dasari A; Mukherjee S
Cancer; 2020 Feb; 126(4):792-799. PubMed ID: 31714595
[TBL] [Abstract][Full Text] [Related]
23. Second primary cancers and survival among neuroendocrine tumor patients.
Bateni SB; Coburn NG; Law C; Singh S; Myrehaug S; Assal A; Hallet J
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184947
[TBL] [Abstract][Full Text] [Related]
24. The epidemiology of metastases in neuroendocrine tumors.
Riihimäki M; Hemminki A; Sundquist K; Sundquist J; Hemminki K
Int J Cancer; 2016 Dec; 139(12):2679-2686. PubMed ID: 27553864
[TBL] [Abstract][Full Text] [Related]
25. Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective.
Pinto MP; Muñoz Medel M; Carrillo D; Retamal IN; Bravo ML; Valenzuela Y; Nervi B; Sánchez C; Galindo H; Ibañez C; Peña J; Balmaceda C; Madrid J; Briones J; Torres J; Nilo F; Guarda FJ; Quintana JC; Orellana P; Mondaca S; Acevedo F; Vicentini D; Cordova-Delgado M; Owen GI; Garrido M
Horm Cancer; 2019 Feb; 10(1):3-10. PubMed ID: 30465145
[TBL] [Abstract][Full Text] [Related]
26. Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry.
Metildi C; McLemore EC; Tran T; Chang D; Cosman B; Ramamoorthy SL; Saltzstein SL; Sadler GR
Am Surg; 2013 Oct; 79(10):1068-74. PubMed ID: 24160801
[TBL] [Abstract][Full Text] [Related]
27. Cancer of the colon and rectum in Louisiana.
Chen VW; Wu XC; Ahmed MN; Correa CN; Andrews PA
J La State Med Soc; 1999 Apr; 151(4):189-97. PubMed ID: 10234894
[TBL] [Abstract][Full Text] [Related]
28. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971.
Ellis L; Shale MJ; Coleman MP
Am J Gastroenterol; 2010 Dec; 105(12):2563-9. PubMed ID: 20823835
[TBL] [Abstract][Full Text] [Related]
29. Sociodemographic analysis of patients in radiation therapy oncology group clinical trials.
Chamberlain RM; Winter KA; Vijayakumar S; Porter AT; Roach M; Streeter O; Cox JD; Bondy ML
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):9-15. PubMed ID: 9422552
[TBL] [Abstract][Full Text] [Related]
30. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy.
Eltawil KM; Gustafsson BI; Kidd M; Modlin IM
J Clin Gastroenterol; 2010; 44(10):687-95. PubMed ID: 20375728
[TBL] [Abstract][Full Text] [Related]
31. Pre-existing Symptoms and Healthcare Utilization Prior to Diagnosis of Neuroendocrine Tumors: A SEER-Medicare Database Study.
Shen C; Dasari A; Xu Y; Zhou S; Gu D; Chu Y; Halperin DM; Shih YT; Yao JC
Sci Rep; 2018 Nov; 8(1):16863. PubMed ID: 30442902
[TBL] [Abstract][Full Text] [Related]
32. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands.
Shavers VL; Harlan LC; Winn D; Davis WW
Cancer Metastasis Rev; 2003 Mar; 22(1):25-38. PubMed ID: 12716034
[TBL] [Abstract][Full Text] [Related]
33. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
34. Association of UV index, latitude, and melanoma incidence in nonwhite populations--US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001.
Eide MJ; Weinstock MA
Arch Dermatol; 2005 Apr; 141(4):477-81. PubMed ID: 15837865
[TBL] [Abstract][Full Text] [Related]
35. Malignant neuroendocrine tumors: incidence and outcomes in pediatric patients.
Allan B; Davis J; Perez E; Lew J; Sola J
Eur J Pediatr Surg; 2013 Oct; 23(5):394-9. PubMed ID: 23444065
[TBL] [Abstract][Full Text] [Related]
36. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.
Henley SJ; King JB; German RR; Richardson LC; Plescia M;
MMWR Surveill Summ; 2010 Nov; 59(9):1-25. PubMed ID: 21102407
[TBL] [Abstract][Full Text] [Related]
37. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
Hausauer AK; Keegan TH; Chang ET; Clarke CA
Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
[TBL] [Abstract][Full Text] [Related]
38. A population-based comparison of European and North American sinonasal cancer survival.
Unsal AA; Kılıç S; Dubal PM; Baredes S; Eloy JA;
Auris Nasus Larynx; 2018 Aug; 45(4):815-824. PubMed ID: 29056464
[TBL] [Abstract][Full Text] [Related]
39. Causes of Death After Neuroendocrine Tumors Diagnosis: A US Population-Based Analysis.
Sonbol MB; Saad AM; Gonzalez-Velez M; Starr J; Halfdanarson TR
Pancreas; 2021 Jan; 50(1):47-53. PubMed ID: 33370022
[TBL] [Abstract][Full Text] [Related]
40. Lung cancer incidence trends in black and white young adults by gender (United States).
Polednak AP
Cancer Causes Control; 2004 Sep; 15(7):665-70. PubMed ID: 15280624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
